Projected Income Statement: GENFIT

Forecast Balance Sheet: GENFIT

Forecast Balance Sheet - GENFIT
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -185 -65.3 -7.61 -19.7 -95.5 57.9 -46.9 -124
Change - 64.7% 88.35% -158.87% -384.77% 160.61% -181% -164.39%
Announcement Date 4/7/22 4/13/23 4/4/24 4/24/25 4/2/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: GENFIT

Fiscal Period: December 2021 2023 2024 2025 2026 2027 2028
CAPEX 1 0.537 0.414 0.899 1.347 1.9 2.1 2.25
Change - - 117.15% 49.83% 41.05% 10.53% 7.14%
Free Cash Flow (FCF) 1 99.38 -55.84 14.65 -27.59 19.9 13.55 41.5
Change - - 126.23% -288.33% 172.13% -31.91% 206.27%
Announcement Date 4/7/22 4/4/24 4/24/25 4/2/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: GENFIT

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 40.38% -95.83% -65.29% 7.06% -72.82% 40.11% 62.38% 68.19%
EBIT Margin (%) 37.18% -102.72% -69.62% 4.63% -6.33% 41.79% 65.99% 60.11%
EBT Margin (%) 81.18% -89.72% -74.69% 2.6% -121.63% 11.84% 83.03% 96.74%
Net margin (%) 78.59% -89.28% -75.69% 2.12% -120.89% -7.97% 31.52% 31.67%
FCF margin (%) 116.12% - -146.28% 20.65% -38.79% 24.71% 10.56% 23.69%
FCF / Net Income (%) 147.75% - 193.27% 972.06% 32.09% -310.21% 33.5% 74.79%

Profitability

        
ROA - - - - - - - -
ROE - -22.21% -35.57% 2.2% - 49.82% 509.19% 134.37%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - 1.79x - -
Debt / Free cash flow - - - - - 2.91x - -

Capital Intensity

        
CAPEX / Current Assets (%) 0.63% - 1.08% 1.27% 1.89% 2.36% 1.64% 1.28%
CAPEX / EBITDA (%) 1.55% - -1.66% 17.96% -2.6% 5.88% 2.62% 1.88%
CAPEX / FCF (%) 0.54% - -0.74% 6.14% -4.88% 9.55% 15.5% 5.42%

Items per share

        
Cash flow per share 1 1.797 - -1.115 0.3113 -0.5264 0.6922 1.565 2.168
Change - - - 127.91% -269.1% 231.5% 126.04% 38.55%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 1.692 - 1.368 1.39 -0.4505 -0.312 0.3952 1.853
Change - - - 1.67% -132.4% 30.75% 226.69% 368.95%
EPS 1 1.23 -0.48 -0.58 0.03 -1.72 -0.262 0.6621 1.003
Change - -139.02% -20.83% 105.17% -5,833.33% 84.77% 352.69% 51.55%
Nbr of stocks (in thousands) 49,727 49,655 49,712 49,865 49,795 50,031 50,031 50,031
Announcement Date 4/7/22 4/13/23 4/4/24 4/24/25 4/2/26 - - -
1EUR
Estimates
2026 *2027 *
P/E -39.7x 15.7x
PBR -33.3x 26.3x
EV / Sales 7.6x 3.95x
Yield - -

EPS & Dividend

EPS & Dividend - GENFIT


Y-o-Y evolution of P/E

Valuation ratios - P/E - GENFIT
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - GENFIT
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - GENFIT
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.40EUR
Average target price
18.88EUR
Spread / Average Target
+81.54%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - GENFIT